logo
Starmer is driving Britain into ‘irrelevance', warns healthcare boss

Starmer is driving Britain into ‘irrelevance', warns healthcare boss

Yahoo08-02-2025
Sir Keir Starmer is driving the UK into 'irrelevance', the boss of one of Britain's fastest-growing healthcare companies has warned.
Dan Vahdat, chief executive of global healthcare firm Huma Therapeutics, said years of high taxes and a permanent aversion to risk had made the UK an increasingly uncompetitive place to do business.
Huma, which worked with the NHS during the pandemic to help monitor Covid patients at home, is one of dozens of technology 'unicorns' in Britain – a start-up with a value of more than $1bn (£800m).
However, Mr Vahdat said he was spending increasing amounts of time in the US, where Huma has announced a tie-up with pharmaceutical giant Pfizer.
Mr Vahdat said the world's biggest economy had a better work ethic and deeper pots of cash to grow his business.
The entrepreneur said he knew dozens of people who had left or were planning to leave the UK because of changes to Britain's non-dom regime, reforms that were started by the Tories and but deepened by Labour.
He also rebuked Rachel Reeves's decision to increase business asset disposal relief to 18pc in 2026, which he said would discourage people from setting up new businesses.
'It started under the Conservatives but then obviously the new government changed it even more which has led almost everybody that I know – entrepreneurs and executives – saying they will leave by April this year because of inheritance tax.
'And that's not good. Because if you are in a place where all the executives are leaving, nobody else will want to come.'
The Iranian-born entrepreneur also warned the Prime Minister that the UK could quickly be left behind in the AI race unless it sent a clearer message that Britain was open for business
Mr Vahdat said: 'We cannot miss this, because if we miss this, we'll close our eyes and open it 10 years later and be so far behind.
'I have seen how a great country can go from all to nothing with my own eyes. From Egypt to Persia to the Ottoman Empire, they were all the greatest places. And now they're irrelevant. The UK has all the great foundations, including the talent, but every year we lose out, we lose more and it gets harder to bounce back.'
Mr Vahdat said he remained loyal to the UK because it gave him a platform to set up a business.
However, asked where he would list his company if given the opportunity today, Mr Vahdat said: 'From how things look like today, there isn't any point for us to list in the UK.
'Number one, it's the mindset of investors in the UK. They prefer dividends and to play it safe, they prefer low multiples. If you go and tell them I want to build the biggest healthcare company in the world they will laugh at you.
'But as laughable as it is, if that person doesn't give up, they may succeed and that is what the US is great for.'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IPO market heats up: These 4 names prepare to go public next
IPO market heats up: These 4 names prepare to go public next

Yahoo

time20 minutes ago

  • Yahoo

IPO market heats up: These 4 names prepare to go public next

EquityZen head of market insight Brianne Lynch joins Market Domination with Josh Lipton to discuss the initial public offering (IPO) market in light of Figma's (FIG) recent public debut and whether companies need to have an artificial intelligence (AI) story to succeed. She also shares which private companies are likely to go public next. To watch more expert insights and analysis on the latest market action, check out more Market Domination. Which are the possible candidates in your opinion, that would be on your radar, who might be willing to test the public markets this year? Sure. So, you know, several of the names on our IPO outlook for the year have already gone public. But there are a few that we're still waiting on. One of the big ones being Klarna. This is a company that was planning to go public in the spring, tabled those plans given the volatility in the market post deliberation day. Uh but they're reportedly now looking at a September IPO. So that'll be, um, the next of several Fintech IPOs we've seen. You had Circle, um, Chime, eToro. So certainly, uh, Fintech is an area where we're seeing more activity and given Klarna's brand recognition, um, and you know, value in the market, that's one we have our eyes on. Right now if you're going to go public, Brian, do you have to have an AI story? Do you have to be able to just sprinkle some of that AI magic on your S-1? Yeah. I would say at a minimum you have to try. And Figma, you know, that's something that played into their story as well. They had so many case studies of their large enterprise clients saving, you know, lots of time and money because of the AI tools that they've built into their products. So, I think that's a table stake for any company that is looking to go public. And that might be the best option for public market investors at the time because you have to remember a lot of these pure play AI companies are still very young in their life cycle. They're less likely to be going public in the next few years. So yes, that's bringing more investors into the private markets to invest. Uh but to kind of capitalize on that interest, public companies or contenders to go public will also need to have that as part of their story. Do you think there there are certain kinds of private companies, Brian, that would be more likely to receive a warm welcome to the public markets in in this environment against this backdrop? Sure. I mean, we've seen a few examples of what has worked. You know, I talked about a little bit about the need for growth, the need for profitability, but when we look at the companies that may be coming next or even the IPOs we've seen in the first half of the year, it hasn't been just one sector or one industry. You've seen Fintech, um, you've seen crypto, which is obviously growing a lot and given, you know, the regulatory tailwinds, uh, we expect that to continue to be a hot market. Um, but then, you know, Netskope, another name on our outlook, that's a cybersecurity company. Um, StubHub, another one. That's an e-commerce player. So, it's definitely not a, you know, one sector narrative that's driving the market. It's more are you growing? Are you profitable? Do you have the brand name? Um, and do you have a a story that's exciting to investors, uh, especially, uh, given the lack of public companies relative to private companies now. Related Videos Berkshire Hathaway earnings: 'Perfect' stock to own when 'worried' Tesla must pay $240M+ for deadly 2019 car crash: What to know Fed Governor Adriana Kugler to resign Dow falls more than 500 points on jobs report, tariffs Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

TTEC Provides Update on Potential Take Private Transaction
TTEC Provides Update on Potential Take Private Transaction

Yahoo

time20 minutes ago

  • Yahoo

TTEC Provides Update on Potential Take Private Transaction

AUSTIN, Texas, Aug. 1, 2025 /PRNewswire/ -- TTEC Holdings, Inc. (NASDAQ:TTEC), a leading global CX (customer experience) technology and services innovator for AI-enabled CX solutions, announced today that July 31, 2025, the Board of Directors (the "Board") of TTEC Holdings, Inc. ("TTEC" or the "Company") received a letter from TTEC founder, Chairman and Chief Executive Officer, Kenneth Tuchman advising the Board that due to market conditions Mr. Tuchman has determined not to pursue his previously announced unsolicited, preliminary non-binding proposal of September 27, 2024 to acquire the outstanding shares of the Company that he and his controlled affiliates do not already own. The Board of Directors has full confidence that TTEC, led by Mr. Tuchman and TTEC's executive leadership team, will continue to thrive, as a public company, in its mission to support clients in the increasingly complex CX ecosystem. As previously reported, TTEC will release its earnings results for Q2 2025 after the market closes on Thursday, August 7, 2025. The company will then host a live webcast and conference call at 8:30 a.m. ET on Friday, August 8, 2025. ABOUT TTECTTEC (pronounced T-TEC) Holdings, Inc. (NASDAQ:TTEC) is a leading global CX (customer experience) technology and services innovator for AI-enabled digital CX solutions. Serving iconic and disruptive brands, TTEC's outcome-based solutions span the entire enterprise, touch every virtual interaction channel, and improve each step of the customer journey. Leveraging next-gen digital technology, the Company's TTEC Digital business designs, builds, and operates omnichannel contact center technology, CRM, AI and analytics solutions. The Company's TTEC Engage business delivers AI-enabled customer engagement, customer acquisition and growth, tech support, back office, and fraud prevention services. Founded in 1982, the Company's singular obsession with CX excellence has earned it leading client, customer, and employee satisfaction scores across the globe. The Company's employees operate on six continents and bring technology and humanity together to deliver happy customers and differentiated business results. To learn more, visit us at Corporate Comms Investor Relations Meredith Matthews Robert Belknapp View original content to download multimedia: SOURCE TTEC Holdings, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

CDC bars expert groups from advising on vaccines
CDC bars expert groups from advising on vaccines

The Hill

time22 minutes ago

  • The Hill

CDC bars expert groups from advising on vaccines

Click in for more news from The Hill{beacon} Health Care Health Care The Big Story CDC bars expert groups from advising on vaccines The Centers for Disease Control and Prevention (CDC) told some expert groups that they will no longer be able to help review scientific data used to issue vaccine recommendations. © APSome members of the Advisory Committee on Immunization Practice's (ACIP) working groups, including physician groups and infectious disease specialists, were sent e-mails late Thursday notifying them that they will no longer serve on the subcommittees. The groups were removed from the subcommittees because they were deemed biased by the Trump administration, according to a copy of the email shared with The Hill. "By definition, Liason organizations are special interest groups and therefore are expected to have a 'bias' based on their constituency/and or population that they represent," the email reads. "It is important that the ACIP Workgroup activities remain free of influence from any special interest groups so ACIP workgroups will no longer include Liason organizations." Eight of the advisory groups released a joint statement Friday saying they are 'deeply disappointed' that they are now barred from informing the development of vaccine recommendations. 'For decades liaisons from our organizations have reviewed published and unpublished data and literature related to vaccine efficacy, effectiveness, and safety and provided unbiased input for ACIP's consideration,' the statement reads. 'To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines.' The groups, which include the American Medical Association, as well as the Infectious Diseases Society of America, called on the Trump administration to reconsider their exclusion from the vaccine review process. A spokesperson for the Department of Health and Human Services (HHS), which oversees the CDC, said that experts will continue to be included in the review process based on 'relevant experience and expertise." 'Under the old ACIP, outside pressure to align with vaccine orthodoxy limited asking the hard questions,' the spokesperson wrote. 'The old ACIP members were plagued by conflicts of interest, influence and bias.' The notice is the latest move from the Trump administration to shake up the nation's vaccine policy and is another major change to the CDC's advisory panel on vaccines. HHS Secretary Robert F. Kennedy Jr abruptly fired all 17 sitting members of ACIP in early June, accusing them of having conflicts of interest and rubber-stamping decisions related to the COVID-19 vaccine. He then replaced the panel with eight hand-picked appointees, including some vaccine skeptics. Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel, Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads How policy will be impacting the health care sector this week and beyond: Most adults do not plan on getting COVID-19 shot amid vaccine policy changesMore than half of American adults — 59 percent — say they do not expect to get the COVID-19 booster shot this autumn, according to new poll findings from health care policy group KFF. Poll results show 23 percent of U.S. adult respondents said they will 'probably not' get the vaccine, while 37 percent said they will 'definitely not' get the shot. Americans who said they will 'probably' or 'definitely' not get the shot were … Full Story Blue states challenge Trump's restrictions on gender-affirming care More than a dozen Democratic attorneys general announced a lawsuit challenging recent moves by President Trump's administration to severely restrict access to gender-affirming health care for anyone under 19, including in states where treatment is legal and protected by law. Full Story Fired vaccine board members warn of fallout from RFK Jr. policiesRecently removed members of a Centers for Disease Control and Prevention (CDC) vaccine advisory panel warn that Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s move to replace them shows he is 'abandoning' rigorous scientific review and open deliberation. Kennedy fired all 17 sitting members of the Advisory Committee on Immunization Practices (ACIP) in early June, accusing members of having conflicts of … Full Story In Other News Branch out with a different read: Number of Texans receiving out-of-state abortions quadrupled between 2021 and 2023 AUSTIN (KXAN) — Texans who sought an abortion out of state more than quadrupled between 2021 and 2023 after a state law went into effect that bans the procedure in almost all cases. Data from the Texas Health and Human Services Commission (HHSC) shows at least 7,844 Texas residents received an abortion in a different state in 2023, up from 4,718 in 2022 and 1,712 in 2021. Still the total number of abortions for Texas residents … Full Story Around the Nation Local and state headlines on health care:More than 2,000 DACA recipients in California to lose health insurance (the San Francisco Chronicle) Some rural Texas seen THC as a lifeline for their health and economy (The Texas Tribune) Illinois becomes first state to require mental health screenings for students (ABC) What We're Reading Health news we've flagged from other outlets: Medicare, Medicaid plans to experiment with covering weight loss drugs (The Washington Post) Wildfire smoke and unhealthy air fill the Midwest before spreading to the East (The Washington Post) Remember running a mile in school? The Presidential Fitness Test is coming back (NPR) You're all caught up. See you next week! Close Thank you for signing up! Subscribe to more newsletters here The latest in politics and policy. Direct to your inbox. Sign up for the Health Care newsletter Subscribe

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store